From the Wires
Swedish Medical Center Leads the Way for Patients Suffering from Acid Reflux/GERD
Denver Provider Is the Only One in the Region to Perform New Procedure
By: PR Newswire
Dec. 12, 2012 02:47 PM
DENVER, Dec. 12, 2012 /PRNewswire/ -- Rocky Mountain-region patients living with Acid Reflux disease, also known as GERD, have welcome relief – literally and figuratively – at the hands of Swedish Medical Center's (Live Link to www.SwedishHospital.com) Reginald Bell, M.D. Bell is the only physician in the region performing a new procedure in patients suffering from this debilitating disease. It's known as the LINX® Reflux Management procedure.
Acid Reflux, or GERD as it is sometimes called, is a chronic and often life-long condition in which the acidic liquid content of one's stomach regurgitates back into the esophagus. Inflaming the lining of the esophagus, it leaves patients with an intense burning sensation. While medication can help in less serious cases, for many, there is no relief, until now. The LINX® System is a minimally invasive laparoscopic procedure that implants a series of interlinked titanium beads with magnetic cores into the esophagus just above the stomach. The magnetic attraction between the beads augments the existing esophageal sphincter's barrier function to prevent reflux. According to Bell, who has performed the procedure on a handful of Denver-area patients, the LINX treatment is a good choice for patients who are in the early stages of GERD.
"We are excited to be able to offer the LINX as a therapeutic option to patients with GERD," Bell says. "I am amazed at the number of patients with GERD who are unaware that there are options other than taking a pill for the rest of their lives! We have worked to become specialists in the diagnosis and minimally invasive treatment of GERD."
Swedish Medical Center patient Cindy Bledsoe, 57, was the ideal candidate for the LINX implant, says Bell, because she had medically resistant symptoms and early reflux. She did not have a hiatal hernia and only mild increases in esophageal acid exposure. In this setting, he says, a minimally invasive procedure with a low risk/side effect profile is desirable. Bledsoe, a first-grade teacher, was plagued by a continuous and chronic cough, often appearing as if she was choking at times. In addition, her oxygen saturation level was at 88 percent and doctors advised her that being significantly overweight contributed to her health problems. Several doctors and tests later, Bledsoe was referred to Bell, who performed the LINX procedure on her in October.
"Before the procedure, acid reflux/GERD controlled my life. And the cough was actually scary for my first-grade students," Bledsoe says. "Immediately after the LINX procedure, however, the cough went away and my oxygen levels went back up to between 96-98 percent."
Bledsoe calls the decision to have the LINX procedure "life changing," and has been removed from some of her pre-diagnosis medications as a result.
"LINX was designed specifically for this group of patients whose symptoms are not controlled adequately by medication and who do not have big hiatal hernias, bad esophagitis or other things we see with more advanced disease," Bell says of the device manufactured by Torax® Medical, Inc.
The LINX System is currently the only available device for the treatment of GERD approved by the FDA through its rigorous PMA process.
According to Bell, in a clinical trial of 100 patients, 92% achieved freedom from daily dependence on PPIs, 90% experienced a reduction in total acid exposure time, 93% achieved significant symptom improvement and the percentage of patients reporting moderate to severe regurgitation was reduced from 57% to 1% after the LINX procedure.
CONTACT: Betsy Donnelly
This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.
SOURCE Swedish Medical Center
SOA World Latest Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week